Fed. Circ. Lets Endo Opana Patent Win Stand
The Federal Circuit on Tuesday declined bids by Roxane Laboratories Inc. and Actavis Inc. to review a panel's ruling that settlements allowing the companies to sell generic versions of Endo Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article